Alto Neuroscience Wants to Revolutionize Mental Health Treatment

Fresh of its IPO at the NYSE, CEO of Alto Neuroscience Dr. Amit Etkin discusses how the company wants to innovate psychiatric medicine.
More Videos
CES 2025: Top Tech to Watch
Jason Hiner, Editor in Chief of ZDNET, breaks down the best tech that came out of CES 2025, including Nvidia's Cosmos, New TV Tech, Roborok Saros Z70 and more.
Load More